Search: WFRF:(Ljungberg Karin) > (2005-2009) > Expression of eryth...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03005naa a2200373 4500 | |
001 | oai:DiVA.org:umu-22455 | |
003 | SwePub | |
008 | 090511s2009 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-224552 URI |
024 | 7 | a https://doi.org/10.1159/0002168442 DOI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Papworth, Karin,d 1964-u Umeå universitet,Onkologi4 aut0 (Swepub:umu)kanpah98 |
245 | 1 0 | a Expression of erythropoietin and its receptor in human renal cell carcinoma |
264 | 1 | b Springer Science and Business Media LLC,c 2009 |
338 | a print2 rdacarrier | |
520 | a Objective: To investigate the prognostic impact of erythropoietin (EPO) and EPO-receptor (EPO-R) expression in tumour as well as serum EPO in patients with renal cell carcinoma (RCC). Methods: Using immunohistochemistry, EPO and EPO-R were assessed in tissue microarrays from 195 RCCs. RCC type, TNM stage, nuclear grade, survival, EPO and haemoglobin (Hb) levels in blood were registered. Results: Strong expression of EPO and EPO-R in tumour tissue was found in 83 and 56%, respectively. EPO and EPO-R expression differed between RCC types. Serum EPO and blood Hb did not correlate to the expression of EPO or EPO-R. A positive correlation was found between the expression of EPO and EPO-R (p = 0.028). Survival was not related to tumour EPO, whereas strong EPO-R expression indicated a non-significantly worse prognosis. Serum EPO correlated positively to TNM stage and nuclear grade and negatively to survival. A multivariate analysis showed that TNM stage and nuclear grade were independent prognostic factors. Tumour EPO and EPO-R expression as well as serum EPO added no independent prognostic information. Conclusion: No correlation between EPO or EPO-R in tumour tissue and serum EPO or blood Hb was found. Neither EPO, EPO-R in tumour tissue nor serum EPO are independent prognostic factors. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Oncology | |
653 | a Onkologi | |
653 | a Oncology | |
653 | a onkologi | |
700 | 1 | a Bergh, Andersu Umeå universitet,Patologi4 aut0 (Swepub:umu)anbe0010 |
700 | 1 | a Grankvist, Kjellu Umeå universitet,Klinisk kemi4 aut0 (Swepub:umu)kjgr0002 |
700 | 1 | a Ljungberg, Börjeu Umeå universitet,Urologi och andrologi4 aut0 (Swepub:umu)bolj0001 |
700 | 1 | a Rasmuson, Torgnyu Umeå universitet,Onkologi4 aut0 (Swepub:umu)tora0001 |
710 | 2 | a Umeå universitetb Onkologi4 org |
773 | 0 | t Tumor Biologyd : Springer Science and Business Media LLCg 30:2, s. 86-92q 30:2<86-92x 1010-4283x 1423-0380 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-22455 |
856 | 4 8 | u https://doi.org/10.1159/000216844 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view